New Insights into Mechanisms of Immune Checkpoint Inhibitor-Induced Cardiovascular Toxicity
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New Insights into Mechanisms of Immune Checkpoint Inhibitor-Induced Cardiovascular Toxicity
Authors
Keywords
-
Journal
Current Oncology Reports
Volume 22, Issue 7, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-08
DOI
10.1007/s11912-020-00925-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association between myocarditis and other immune‐related adverse events secondary to immune checkpoint inhibitor use
- (2020) Avirup Guha et al. INTERNATIONAL JOURNAL OF CANCER
- BRIEF REPORT: Immune checkpoint inhibitor associated pericarditis
- (2019) Mehmet Altan et al. Journal of Thoracic Oncology
- Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors
- (2019) Nicolas Palaskas et al. AMERICAN JOURNAL OF CARDIOLOGY
- Acral vascular necrosis associated with immune-check point inhibitors: case report with literature review
- (2019) Karam Khaddour et al. BMC CANCER
- Abatacept for Severe Immune Checkpoint Inhibitor–Associated Myocarditis
- (2019) Joe-Elie Salem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular toxicity of immune checkpoint inhibitors in cancer patients: A review when cardiology meets immuno-oncology
- (2019) Dong-Yi Chen et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Immune checkpoint inhibition alters the inflammatory cell composition of human coronary artery atherosclerosis
- (2019) Justine L. Newman et al. CARDIOVASCULAR PATHOLOGY
- Immune Checkpoint Inhibitor-Associated Cardiotoxicity: Current Understanding on Its Mechanism, Diagnosis and Management
- (2019) Yu-Wen Zhou et al. Frontiers in Pharmacology
- Rare, but Severe: Vasculitis and Checkpoint Inhibitors
- (2019) Andrea Katharina Lindner et al. European Urology Focus
- Immune Checkpoint Inhibitor-Associated Myocarditis: A New Challenge for Cardiologists
- (2018) Mauro Frigeri et al. CANADIAN JOURNAL OF CARDIOLOGY
- Cardiac Complications Associated With Checkpoint Inhibition: A Systematic Review of the Literature in an Important Emerging Area
- (2018) Hassan Mir et al. CANADIAN JOURNAL OF CARDIOLOGY
- Immune Checkpoint Inhibitors and Cardiac Toxicity: An Emerging Issue
- (2018) Gilda Varricchi et al. CURRENT MEDICINAL CHEMISTRY
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
- (2018) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors
- (2018) Eleonora De Martin et al. JOURNAL OF HEPATOLOGY
- Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
- (2018) Syed S. Mahmood et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis
- (2018) Javid J Moslehi et al. LANCET
- Kinase-targeted cancer therapies: progress, challenges and future directions
- (2018) Khushwant S. Bhullar et al. Molecular Cancer
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- (2018) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Takotsubo-Like Syndrome in Cancer Patients Treated With Immune Checkpoint Inhibitors
- (2018) Stephane Ederhy et al. JACC-Cardiovascular Imaging
- Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
- (2018) Jun Gong et al. Journal for ImmunoTherapy of Cancer
- Immune checkpoint inhibitors and cardiovascular toxicity
- (2018) Alexander R Lyon et al. LANCET ONCOLOGY
- Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
- (2018) Hussein A. Tawbi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors
- (2018) Daniel Y. Wang et al. JAMA Oncology
- Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
- (2018) Joe-Elie Salem et al. LANCET ONCOLOGY
- New checkpoints in cancer immunotherapy
- (2017) Ling Ni et al. IMMUNOLOGICAL REVIEWS
- Prognostic Value of Cardiac Magnetic Resonance Tissue Characterization in Risk Stratifying Patients With Suspected Myocarditis
- (2017) Christoph Gräni et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Risk of Arterial Thromboembolism in Patients With Cancer
- (2017) Babak B. Navi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
- (2017) Arjun V Balar et al. LANCET
- Cardiovascular Toxicities Associated with Cancer Immunotherapies
- (2017) Daniel Y. Wang et al. Current Cardiology Reports
- Left Ventricular Dysfunction After Treatment With Ipilimumab for Metastatic Melanoma
- (2016) Mary E. Roth et al. AMERICAN JOURNAL OF THERAPEUTICS
- Overexpression of Cytotoxic T-Lymphocyte–Associated Antigen-4 Prevents Atherosclerosis in MiceHighlights
- (2016) Takuya Matsumoto et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review
- (2016) J.M. Michot et al. EUROPEAN JOURNAL OF CANCER
- Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
- (2016) Roy S Herbst et al. LANCET
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- (2016) Douglas B. Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systemic inflammation in a melanoma patient treated with immune checkpoint inhibitors—an autopsy study
- (2016) Viktor H. Koelzer et al. Journal for ImmunoTherapy of Cancer
- Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology
- (2015) Alexander R. Lyon et al. EUROPEAN JOURNAL OF HEART FAILURE
- Apical ballooning and cardiomyopathy in a melanoma patient treated with ipilimumab: a case of takotsubo-like syndrome
- (2015) Benjamin P Geisler et al. Journal for ImmunoTherapy of Cancer
- Upregulation of Programmed Death-1 and Its Ligand in Cardiac Injury Models: Interaction with GADD153
- (2015) Babak Baban et al. PLoS One
- Programmed Death Ligand 1 Regulates a Critical Checkpoint for Autoimmune Myocarditis and Pneumonitis in MRL Mice
- (2014) J. A. Lucas et al. JOURNAL OF IMMUNOLOGY
- Non-invasive assessment of experimental autoimmune myocarditis in rats using a 3 T clinical MRI scanner
- (2013) Shunit Rinkevich-Shop et al. European Heart Journal-Cardiovascular Imaging
- CTLA4-IgG ameliorates homocysteine-accelerated atherosclerosis by inhibiting T-cell overactivation in apoE−/− mice
- (2012) Kongyang Ma et al. CARDIOVASCULAR RESEARCH
- PD-1 Protects against Inflammation and Myocyte Damage in T Cell-Mediated Myocarditis
- (2012) M. L. Tarrio et al. JOURNAL OF IMMUNOLOGY
- Mechanistic links between acute respiratory tract infections and acute coronary syndromes
- (2012) Rohit Bazaz et al. JOURNAL OF INFECTION
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impairment of the Programmed Cell Death-1 Pathway Increases Atherosclerotic Lesion Development and Inflammation
- (2011) De-xiu Bu et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Impaired thymic tolerance to α-myosin directs autoimmunity to the heart in mice and humans
- (2011) HuiJuan Lv et al. JOURNAL OF CLINICAL INVESTIGATION
- Progress and challenges in translating the biology of atherosclerosis
- (2011) Peter Libby et al. NATURE
- Cutting Edge: CTLA-4-B7 Interaction Suppresses Th17 Cell Differentiation
- (2010) H. Ying et al. JOURNAL OF IMMUNOLOGY
- Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases
- (2009) Anna Maria Di Giacomo et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The role of CD4+CD25+ regulatory T cells in macrophage-derived foam-cell formation
- (2009) Jing Lin et al. JOURNAL OF LIPID RESEARCH
- Mechanisms maintaining peripheral tolerance
- (2009) Daniel L Mueller NATURE IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now